About Nuromol Dual Action Pain Relief
ABOUT NUROMOL DUAL ACTION PAIN RELIEF
THE FIRST CHOICE FOR SECOND LINE OTC PAIN RELIEF4,5
* Based on 2 tablet dose of Nuromol
For adults aged 18 and over
One tablet to be taken up to three times a day with water. Leave at least six hours between doses. If the one tablet does not control symptoms, a maximum of two tablets may be taken up to three times a day. Leave at least six hours between doses. To minimise side effects, it is recommended that Nuromol Dual Action Pain Relief is taken with food.4
The lowest effective dose should be used for the shortest duration necessary to relieve symptoms. Customers should consult their GP if their symptoms persist or worsen or if the product is required for more than three days.
AVAILABLE AS A GSL PRODUCT FOR SELF-SELECTION
Customers should be advised that the maximum dose is six tablets in 24 hours. This product contains paracetamol and ibuprofen and should not be taken with other products containing paracetamol or NSAIDs.
This communication has been approved by the NPA. The NPA will have no liability to any person or entity with liability, loss or damage caused or alleged to have been caused directly or indirectly by information therein. The NPA is not responsible for the content of any non-NPA websites mentioned in this programme or for the accuracy of any information found there. The fact that a website, organisation or product is mentioned in the programme does not mean that the NPA either approves of it or endorses it.
1. Kantar Worldpanel Pain LinkQ study, data to December 2020 (n=1000)
2. NICE. Analgesia for mild to moderate pain. https://cks.nice.org.uk/topics/analgesia-mild-to-moderate-pain/
3. NICE Guideline NG59. Low back pain and sciatica in o ver 16s: assessment and management. https://www.nice.org.uk/guidance/ng59/chapter/Recommendations#non-invasive-treatments-for-low-back-pain-and-sciatica
4. Nuromol Dual Action Pain Relief 200mg/500mg Tablets. Summary of Product Characteristics. Updated December 2021. https://www.medicines.org.uk/emc/product/4967
5. Daniels SE, et al. A randomiz ed, five-parallel-group, placebo-controlled trial comparing the efficacy and tolerability of analgesic combinations including a novel single-tablet combination of ibuprofen/paracetamol for postoperative dental pain. Pain. 2011;152:632-642.
All references last accessed March 2022
Nuromol Dual Action Pain Relief ibuprofen 200 mg/paracetamol 500 mg tablets. For the temporary relief of mild to moderate pain which has not been relieved by ibuprofen or paracetamol individually such as migraine, headache, backache, period pain, dental pain, rheumatic and muscular pain, cold and flu symptoms, sore throat and fever. Licence Holder: Reckitt Benckiser Healthcare (UK) Limited, Slough, SL1 3UH. Legal Classification: GSL. MRRP: 12 tablets £3.99 , 16 tablets £4.99 Information about this product, including adverse reactions, precautions, contra-indications, and method of use can be found at https://www.medicines.org.uk/emc/product/4967
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard, or search for the MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Reckitt Benckiser Healthcare (UK) ltd on: 0333 200 5345